Table of contents
Volume 80, Issue 11
Published online 9 July 1999 (1679-1866)
Editorials
Adjuvant interferon in the treatment of melanoma FREE
M R Middleton
Br J Cancer 80: 1679-1680; doi:10.1038/sj.bjc.6690582
The leucocyte nadir, a predictor of chemotherapy efficacy? FREE
S Kvinnsland
Br J Cancer 80: 1681; doi:10.1038/sj.bjc.6690583
Regular Articles
Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis FREE
L Hilakivi-Clarke, I Onojafe, M Raygada, E Cho, T Skaar, I Russo and R Clarke
Br J Cancer 80: 1682-1688; doi:10.1038/sj.bjc.6690584
Fractionated 
-irradiation renders tumour cells more responsive to apoptotic signals through CD95 FREE
M A Sheard, P H Krammer and J Zaloudik
Br J Cancer 80: 1689-1696; doi:10.1038/sj.bjc.6690585
Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis FREE
E K Rofstad and T Danielsen
Br J Cancer 80: 1697-1707; doi:10.1038/sj.bjc.6690586
Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line FREE
R Hasina, K Matsumoto, N Matsumoto-Taniura, I Kato, M Sakuda and T Nakamura
Br J Cancer 80: 1708-1717; doi:10.1038/sj.bjc.6690587
Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells FREE
G A Koning, A Gorter, G L Scherphof and J A A M Kamps
Br J Cancer 80: 1718-1725; doi:10.1038/sj.bjc.6690588
Increased cytotoxicity and bystander effect of 5-fluorouracil and 5'-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase FREE
A Evrard, P Cuq, J Ciccolini, L Vian and J-P Cano
Br J Cancer 80: 1726-1733; doi:10.1038/sj.bjc.6690589
Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361) FREE
P T Todorov, W N Field and M J Tisdale
Br J Cancer 80: 1734-1737; doi:10.1038/sj.bjc.6690590
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced 
1-acid glycoprotein binding FREE
N J Curtin, K J Bowman, R N Turner, B Huang, P J Loughlin, A H Calvert, B T Golding, R J Griffin and D R Newell
Br J Cancer 80: 1738-1746; doi:10.1038/sj.bjc.6690591
Mathematical and experimental analysis of localization of anti-tumour antibody–enzyme conjugates FREE
T L Jackson, S R Lubkin, N O Siemers, D E Kerr, P D Senter and J D Murray
Br J Cancer 80: 1747-1753; doi:10.1038/sj.bjc.6690592
Wheatgerm agglutinin-mediated toxicity in pancreatic cancer cells FREE
R E Schwarz, D C Wojciechowicz, A I Picon, M A Schwarz and P B Paty
Br J Cancer 80: 1754-1762; doi:10.1038/sj.bjc.6690593
Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF FREE
P Poikonen, T Saarto, J Lundin, H Joensuu and C Blomqvist
Br J Cancer 80: 1763-1766; doi:10.1038/sj.bjc.6690594
Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice FREE
A Ravaud, C Bedane, L Geoffrois, T Lesimple and M Delaunay
Br J Cancer 80: 1767-1769; doi:10.1038/sj.bjc.6690595
The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses FREE
T Sheard and P Maguire
Br J Cancer 80: 1770-1780; doi:10.1038/sj.bjc.6690596
High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma FREE
M Halme, A Knuuttila, T Vehmas, L Tammilehto, M Mäntylä, J Salo and K Mattson
Br J Cancer 80: 1781-1785; doi:10.1038/sj.bjc.6690597
Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II FREE
C J Twelves, C Gardner, A Flavin, J Sludden, I Dennis, J de Bono, P Beale, P Vasey, C Hutchison, M A Macham, A Rodriguez, I Judson and N M Bleehen for the CRC Phase I/II Committee
Br J Cancer 80: 1786-1791; doi:10.1038/sj.bjc.6690598
Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma FREE
M I Koukourakis, N Bahlitzanakis, M Froudarakis, A Giatromanolaki, V Georgoulias, S Koumiotaki, M Christodoulou, G Kyrias, J Skarlatos, J Kostantelos and K Beroukas
Br J Cancer 80: 1792-1796; doi:10.1038/sj.bjc.6690599
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma FREE
W Scheithauer, G V Kornek, M Raderer, M Hejna, J Valencak, J Miholic, E Kovats, F Lang, J Funovics, E Bareck and D Depisch
Br J Cancer 80: 1797-1802; doi:10.1038/sj.bjc.6690600
Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients FREE
K P Hickey, K P Boyle, H M Jepps, A C Andrew, E J Buxton and P A Burns
Br J Cancer 80: 1803-1808; doi:10.1038/sj.bjc.6690601
Ki-67 is strongly prognostic in synovial sarcoma: analysis based on 86 patients from the Scandinavian Sarcoma Group Register FREE
B T Skytting, H C Bauer, R Perfekt, G Nilsson and O Larsson
Br J Cancer 80: 1809-1814; doi:10.1038/sj.bjc.6690602
Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy FREE
P J Jenkins, S A Sohaib, P J Trainer, T A Lister, G M Besser and R Reznek
Br J Cancer 80: 1815-1819; doi:10.1038/sj.bjc.6690603
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases FREE
N Kinugasa, T Higashi, K Nouso, H Nakatsukasa, Y Kobayashi, M Ishizaki, N Toshikuni, K Yoshida, S Uematsu and T Tsuji
Br J Cancer 80: 1820-1825; doi:10.1038/sj.bjc.6690604
Short Communications
A comparison of national cancer registry and direct follow-up in the ascertainment of ovarian cancer FREE
N MacDonald, K Sibley, A Rosenthal, U Menon, A Jeyarajah, D Oram and I Jacobs
Br J Cancer 80: 1826-1827; doi:10.1038/sj.bjc.6690605
Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53 FREE
H Y S Ngan, V W S Liu and S S Liu
Br J Cancer 80: 1828-1829; doi:10.1038/sj.bjc.6690606
Regular Articles
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer FREE
D T Silverman, M Schiffman, J Everhart, A Goldstein, K D Lillemoe, G M Swanson, A G Schwartz, L M Brown, R S Greenberg, J B Schoenberg, L M Pottern, R N Hoover and J F Fraumeni Jr
Br J Cancer 80: 1830-1837; doi:10.1038/sj.bjc.6690607
Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan FREE
C-S Huang, C-Y Shen, K-J Chang, S-M Hsu and H-D Chern
Br J Cancer 80: 1838-1843; doi:10.1038/sj.bjc.6690608
Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study FREE
P A McKinney, E Juszczak, E Findlay, K Smith and C S Thomson
Br J Cancer 80: 1844-1851; doi:10.1038/sj.bjc.6690609
Lifetime exercise activity and breast cancer risk among post-menopausal women FREE
C L Carpenter, R K Ross, A Paganini-Hill and L Bernstein
Br J Cancer 80: 1852-1858; doi:10.1038/sj.bjc.6690610
Risk factors for testicular germ cell tumours by histological tumour type FREE
C A C Coupland, C E D Chilvers, G Davey, M C Pike, R T D Oliver, D Forman and on behalf of the United Kingdom Testicular Cancer Study Group
Br J Cancer 80: 1859-1863; doi:10.1038/sj.bjc.6690611
Book Review
Top of pageErratum
Erratum FREE
U Hinrichs, G R Rutteman and H Nederbragt
Br J Cancer 80: 1866; doi:10.1038/sj.bjc.6690613
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
